Intracranial injection of recombinant stromal-derived factor-1 alpha (SDF-1α) attenuates traumatic brain injury in rats

Inflammation Research

Volumn 63, Issue 4, 2014, Pages 287-297

  Sun, Weifeng ^a,b   Liu, Jiafeng ^b   Huan, Yu ^b   Zhang, Chaodong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Harbin First Hospital   (China)

Author keywords

ERK pathway; Inflammation; Neuronal degradation and apoptosis; NF B pathway; SDF 1 ; TBI

Indexed keywords

CASPASE 3; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; NEUTRALIZING ANTIBODY; NITRIC OXIDE; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN DAMAGE; BRAIN EDEMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAD INJURY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRACRANIAL DRUG ADMINISTRATION; MALE; NERVE CELL DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BRAIN; BRAIN EDEMA; BRAIN INJURIES; CHEMOKINE CXCL12; CYTOKINES; MALE; NEURONS; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 84896549046     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0699-8     Document Type: Article

References (58)

1. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728-41. (Pubitemid 351957931)
2. Davis AE. Mechanisms of traumatic brain injury: biomechanical, structural and cellular considerations. Crit Care Nurs Q. 2000;23(3):1-13.
3. Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J Neurotrauma. 2010;27(8):1529-40.
4. Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci. 2013;14(2):128-42.
5. Bacon KB, Harrison JK. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J Neuroimmunol. 2000;104(1):92-7. (Pubitemid 30100542)
6. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2(2):108-15. doi:10.1038/84209. (Pubitemid 33707927)
7. Esche C, Stellato C, Beck LA. Chemokines: key players in innate and adaptive immunity. J Invest Dermatol. 2005;125(4):615-28.
8. Banisadr G, Rostene W, Kitabgi P, Parsadaniantz SM. Chemokines and brain functions. Curr Drug Targets Inflamm Allergy. 2005;4(3):387-99. (Pubitemid 40879603)
9. Rostene W, Kitabgi P, Parsadaniantz SM. Chemokines: a new class of neuromodulator? Nat Rev Neurosci. 2007;8(11):895-903.
10. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006;203(9):2201-13. (Pubitemid 44352240)
11. Mithal DS, Banisadr G, Miller RJ. CXCL12 signaling in the development of the nervous system. J Neuroimmune Pharmacol. 2012;7(4):820-34.
12. Werner L, Guzner-Gur H, Dotan I. Involvement of CXCR4/CXCR7/CXCL12 interactions in inflammatory bowel disease. Theranostics. 2013;3(1):40-6.
13. Liu X, Zhou C, Li Y, Ji Y, Xu G, Wang X, et al. SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition. PLoS One. 2013;8(1):e54077.
14. Li S, Wei M, Zhou Z, Wang B, Zhao X, Zhang J. SDF-1 alpha induces angiogenesis after traumatic brain injury. Brain Res. 2012;1444:76-86.
15. Qiu R, Cai A, Dong Y, Zhou Y, Yu D, Huang Y, et al. SDF-1 alpha upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects. J Biomed Sci. 2012;19:99.
16. Mori T, Wang X, Aoki T, Lo EH. Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J Neurotrauma. 2002;19(11):1411-9. (Pubitemid 35403670)
17. Wang JW, Wang HD, Cong ZX, Zhang XS, Zhou XM, Zhang DD. Activation of metabotropic glutamate receptor 5 reduces the secondary brain injury after traumatic brain injury in rats. Biochem Biophys Res Commun. 2013;430(3):1016-21.
18. Chen CH, Toung TJ, Sapirstein A, Bhardwaj A. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. J Cereb Blood Flow Metab. 2006;26(7):951-8. (Pubitemid 43980411)
19. Hilton GD, Stoica BA, Byrnes KR, Faden AI. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab. 2008;28(11):1845-59.
20. Chen SF, Tsai HJ, Hung TH, Chen CC, Lee CY, Wu CH, et al. Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3 K/Akt signaling after experimental traumatic brain injury. PLoS One. 2012;7(9):e45763.
21. Zhuang Z, Zhou ML, You WC, Zhu L, Ma CY, Sun XJ, et al. Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci. 2012;13:47.
22. Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27(5):894-908. (Pubitemid 46659028)
23. Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats. Part I: pathophysiology and biomechanics. J Neurosurg. 1994;80(2):291-300. (Pubitemid 24036501)
24. Demir H, Onur OE, Denizbasi A, Akoglu H, Eroglu SE, Ozpolat C, et al. The effects of adrenomedullin in traumatic brain injury. Peptides. 2013;43:27-31.
25. Wang JW, Wang HD, Zhong WZ, Li N, Cong ZX. Expression and cell distribution of metabotropic glutamate receptor 5 in the rat cortex following traumatic brain injury. Brain Res. 2012;1464:73-81.
26. Zhang D, Hu Y, Sun Q, Zhao J, Cong Z, Liu H, et al. Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats. Neuroscience. 2013;238:209-17.
27. Clausen F, Hanell A, Israelsson C, Hedin J, Ebendal T, Mir AK, et al. Neutralization of interleukin-1 beta reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur J Neurosci. 2011;34(1):110-23.
28. Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry. 2006;7(1):51-5. (Pubitemid 43878527)
29. Kanbak G, Kartkaya K, Ozcelik E, Guvenal AB, Kabay SC, Arslan G, et al. The neuroprotective effect of acute moderate alcohol consumption on caspase-3 mediated neuroapoptosis in traumatic brain injury: the role of lysosomal cathepsin L and nitric oxide. Gene. 2013;512(2):492-5.
30. Okiyama K, Smith DH, Gennarelli TA, Simon RP, Leach M, McIntosh TK. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J Neurochem. 1995;64(2):802-9.
31. Eldadah BA, Faden AI. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma. 2000;17(10):811-29.
32. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene. 2005;24(44):6719-28. (Pubitemid 41486802)
33. Cullen SP, Martin SJ. Caspase activation pathways: some recent progress. Cell Death Differ. 2009;16(7):935-8.
34. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol. 2005;15(4):277-89. (Pubitemid 41058773)
35. Yilmaz ER, Kertmen H, Gurer B, Kanat MA, Arikok AT, Erguder BI, et al. The protective effect of 2-mercaptoethane sulfonate (MESNA) against traumatic brain injury in rats. Acta Neurochir (Wien). 2013;155(1):141-9.
36. Mori T, Wang X, Jung JC, Sumii T, Singhal AB, Fini ME, et al. Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J Cereb Blood Flow Metab. 2002;22(4):444-52. (Pubitemid 34273600)
37. Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res. 2011;21(2):223-44.
38. Sanz O, Acarin L, Gonzalez B, Castellano B. NF-kappaB and I kappa B alpha expression following traumatic brain injury to the immature rat brain. J Neurosci Res. 2002;67(6):772-80. (Pubitemid 34226289)
39. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, Zhang L, et al. Stromal cell-derived factor 1 alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab. 2006;26(1):125-34. (Pubitemid 41818076)
40. Yoo J, Seo JJ, Eom JH, Hwang DY. Effects of stromal cell-derived factor 1 alpha delivered at different phases of transient focal ischemia in rats. Neuroscience. 2012;209:171-86.
41. Kremer KN, Peterson KL, Schneider PA, Meng XW, Dai H, Hess AD, et al. CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak. J Biol Chem. 2013;288(32):22899-914.
42. Liu X, Duan B, Cheng Z, Jia X, Mao L, Fu H, et al. SDF-1/ CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell. 2011;2(10):845-54.
43. Zheng H, Dai T, Zhou B, Zhu J, Huang H, Wang M, et al. SDF-1 alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3 K/Akt/eNOS pathway. Atherosclerosis. 2008;201(1):36-42.
44. D'Amelio M, Cavallucci V, Cecconi F. Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 2010;17(7):1104-14.
45. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002;2(9):647-56. (Pubitemid 37328916)
46. Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011;21(1):92-101.
47. Mao W, Yi X, Qin J, Tian M, Jin G. CXCL12 inhibits cortical neuron apoptosis by increasing the ratio of Bcl-2/Bax after traumatic brain injury. Int J Neurosci. 2013. doi:10.3109/00207454.2013.838236.
48. Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide. 1997;1(2):107-20. (Pubitemid 28076552)
49. Lowenstein CJ, Padalko E. iNOS (NOS2) at a glance. J Cell Sci. 2004;117(Pt 14):2865-7. (Pubitemid 39117660)
50. Lu J, Moochhala S, Shirhan M, Ng KC, Tan MH, Teo AL, et al. Nitric oxide induces macrophage apoptosis following traumatic brain injury in rats. Neurosci Lett. 2003;339(2):147-50. (Pubitemid 36254797)
51. Lu J, Moochhala S, Shirhan M, Ng KC, Teo AL, Tan MH, et al. Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study. Neuropharmacology. 2003;44(2):253-63. (Pubitemid 36293265)
52. Lukacs NW, Berlin A, Schols D, Skerlj RT, Bridger GJ. AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am J Pathol. 2002; 160(4):1353-60. (Pubitemid 34411639)
53. Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, et al. A role for CXCL12 (SDF-1 alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol. 2006;177(1-2):27-39. (Pubitemid 44108231)
54. McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J Immunol. 2006;177(11):8053-64. (Pubitemid 44846323)
55. Zhao Y, Luo P, Guo Q, Li S, Zhang L, Zhao M, et al. Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp Neurol. 2012;237(2):489-98.
56. Otani N, Nawashiro H, Fukui S, Nomura N, Yano A, Miyazawa T, et al. Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus. J Cereb Blood Flow Metab. 2002;22(3):327-34. (Pubitemid 34203060)
57. Huang CY, Fujimura M, Noshita N, Chang YY, Chan PH. SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2001;21(2):163-73. (Pubitemid 32143978)
58. Lu DY, Tang CH, Yeh WL, Wong KL, Lin CP, Chen YH, et al. SDF-1 alpha up-regulates interleukin-6 through CXCR4, PI3 K/ Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol. 2009;613(1-3):146-54.